The combination of treosulfan and fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation ...

血管仿佛川流不息的高速公路白细胞、红细胞、血小板像车子一样在疾驰当“汽车工厂”——骨髓出现生产异常无法制造足量的“车辆”——正常血细胞导致血管中的白细胞、红细胞、血小板一种或是多种的数量下降那么人体就会出现感染、贫血或出血的情况这就是骨髓增生异常综合 ...

The FDA has approved GRAFAPEX™ and fludarabine as a preparative regimen in acute myeloid leukemia or myelodysplastic syndrome ...

Myelodysplastic syndromes (MDS) are marked by ineffective hematopoiesis and dysplasia, which elevate the risk of progression to acute myeloid leukemia (AML). The inflammatory environment in MDS alters ...

Exploring the combination with azacitidineStudy led by Medical College of Wisconsin MADRID and CAMBRIDGE, Mass., Jan. 23, 2025 (GLOBE NEWSWIRE) ...

The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell ...

The FDA has approved Grafapex (treosulfan) for use in combination with fludarabine as a preparative regimen for allogeneic HSCT in patients aged 1 year and older with AML or MDS.

It is a group of diseases that affect how blood cells are made. In all subtypes of MDS, a chronic bone marrow problem leads to low levels of blood cells moving around in your bloodstream. Fred Hutch ...

In an interview, Andrew Kuykendall, MD, discussed fedratinib’s potential as an effective option for patients with ...

The study demonstrated a poor prognosis overall for patients with acute myeloid leukemia (AML) who were previously treated ...

of The Ohio State University Comprehensive Cancer Center – James Cancer Hospital, explains how patients with MDS can receive care in the outpatient setting, allowing them to avoid long hospital ...

Oncologist Thomas C. Weiner misdiagnosed Anthony Olson with MDS in 2011. Olson is one of many patients who may have received unnecessary and harmful treatments after being misdiagnosed by Weiner.